Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer. Collier E, Soberanis Pina P, McMullen M, Gonzalez-Ochoa E, et al. Int J Gynecol Cancer 2025 Mar 1:101755. doi: 10.1016/j.ijgc.2025.101755.

Read + Share

Amedeo Smart

Independent Medical Education

Collier E, Soberanis Pina P, McMullen M, Gonzalez-Ochoa E, et al. Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer. Int J Gynecol Cancer 2025 Mar 1:101755. doi: 10.1016/j.ijgc.2025.101755.
PMID: 40122741